Home LiteratureArticle Details
PMID: 3023943 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mutational analysis of a ras catalytic domain.

Molecular and cellular biology ·Vol. 6 ·No. 7 ·1986-07-00 ·Pages 2646-54

Willumsen BM, Papageorge AG, Kung HF, Bekesi E, Robins T, Johnsen M, Vass WC, Lowy DR

Abstract

We used linker insertion-deletion mutagenesis to study the catalytic domain of the Harvey murine sarcoma virus v-rasH transforming protein, which is closely related to the cellular rasH protein. The mutants displayed a wide range of in vitro biological activity, from those that induced focal transformation of NIH 3T3 cells with approximately the same efficiency as the wild-type v-rasH gene to those that failed to induce any detectable morphologic changes. Correlation of transforming activity with the location of the mutations enabled us to identify three nonoverlapping segments within the catalytic domain that were dispensable for transformation and six other segments that were required for transformation. Segments that were necessary for guanosine nucleotide (GDP) binding corresponded to three of the segments that were essential for transformation; two of the three segments share strong sequence homology with other purine nucleotide-binding proteins. Loss of GDP binding was associated with apparent instability of the protein. Lesions in two of the three other required regions significantly reduced GDP binding, while small lesions in the last required region did not impair GDP binding or membrane localization. We speculate that this latter region interacts with the putative cellular target of ras. The results suggest that transforming ras proteins require membrane localization, guanosine nucleotide binding, and an additional undefined function that may represent interaction with their target.

MeSH Terms
Arginine/genetics Cell Transformation, Viral GTP Phosphohydrolases/metabolism Gene Expression Regulation Genes, Viral Guanosine Diphosphate/metabolism Harvey murine sarcoma virus/genetics Mutation Oncogenes Phosphorylation Sarcoma Viruses, Murine/genetics Subcellular Fractions/analysis Threonine/genetics Viral Proteins/analysis,genetics
Chemicals
Viral Proteins Guanosine Diphosphate Threonine Arginine GTP Phosphohydrolases
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Willumsen B M
Papageorge A G
Kung H F
Bekesi E
Robins T
Johnsen M
Vass W C
Lowy D R
References (44)
44 references, click to expand
  1. The p21 ras C-terminus is required for transformation and membrane association.
    Nature. 1984 Aug 16-22;310(5978):583-6 PMID: 6087162
  2. Oncogenes and cancer: the p21 ras genes.
    Cancer Invest. 1984;2(2):109-23 PMID: 6375822
  3. Comparative biochemical properties of normal and activated human ras p21 protein.
    Nature. 1984 Aug 23-29;310(5979):644-9 PMID: 6147754
  4. Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.
    Proc Natl Acad Sci U S A. 1984 Sep;81(17):5305-9 PMID: 6089191
  5. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.
    Nature. 1984 Sep 20-26;311(5983):273-5 PMID: 6148703
  6. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
    Proc Natl Acad Sci U S A. 1984 Sep;81(18):5704-8 PMID: 6148751
  7. Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli.
    Proc Natl Acad Sci U S A. 1984 Nov;81(22):6953-7 PMID: 6438627
  8. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus.
    EMBO J. 1984 Nov;3(11):2581-5 PMID: 6096132
  9. Functional homology of mammalian and yeast RAS genes.
    Cell. 1985 Jan;40(1):19-26 PMID: 2981628
  10. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.
    Nature. 1985 Jan 17-23;313(5999):241-3 PMID: 3918269
  11. Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):376-80 PMID: 2982154
  12. Regional homology in GTP-binding proto-oncogene products and elongation factors.
    J Cyclic Nucleotide Protein Phosphor Res. 1983-1984;9(6):435-48 PMID: 6396323
  13. Sequence of the alpha subunit of photoreceptor G protein: homologies between transducin, ras, and elongation factors.
    Science. 1985 Apr 5;228(4695):96-9 PMID: 3856323
  14. Mammalian and yeast ras gene products: biological function in their heterologous systems.
    Science. 1985 Apr 12;228(4696):179-84 PMID: 3883495
  15. Primary structure of the alpha-subunit of transducin and its relationship to ras proteins.
    Nature. 1985 May 16-22;315(6016):242-5 PMID: 3923359
  16. Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins.
    Cell. 1985 Jul;41(3):763-9 PMID: 3891097
  17. Amino acid sequence of the alpha subunit of transducin deduced from the cDNA sequence.
    Proc Natl Acad Sci U S A. 1985 Jul;82(13):4311-5 PMID: 2409555
  18. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Proc Natl Acad Sci U S A. 1985 Aug;82(16):5280-4 PMID: 3927300
  19. The ras oncogene product p21 is not a regulatory component of adenylate cyclase.
    Nature. 1985 Sep 5-11;317(6032):71-2 PMID: 3929144
  20. Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins.
    Science. 1985 Oct 4;230(4721):32-6 PMID: 3898365
  21. A model for the tertiary structure of p21, the product of the ras oncogene.
    Science. 1985 Oct 4;230(4721):78-82 PMID: 3898366
  22. Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains.
    EMBO J. 1985 Nov;4(11):2893-6 PMID: 2998761
  23. Reconstitution of the GTP-dependent adenylate cyclase from products of the yeast CYR1 and RAS2 genes in Escherichia coli.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):7855-9 PMID: 2999779
  24. Activation of Ha-ras p21 by substitution, deletion, and insertion mutations.
    Mol Cell Biol. 1985 Aug;5(8):1809-13 PMID: 3018526
  25. A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene.
    Mol Cell Biol. 1986 May;6(5):1843-6 PMID: 2431287
  26. Temperature-sensitive RNA polymerase mutants with altered subunit synthesis and degradation.
    Proc Natl Acad Sci U S A. 1975 Jun;72(6):2375-9 PMID: 1094466
  27. The role of guanosine 5'-triphosphate in polypeptide chain elongation.
    Biochim Biophys Acta. 1978 Sep 21;505(1):95-127 PMID: 361078
  28. Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.
    Nature. 1980 Oct 23;287(5784):686-91 PMID: 6253810
  29. The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):3783-7 PMID: 6253989
  30. Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus.
    J Virol. 1982 Apr;42(1):253-61 PMID: 6283143
  31. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.
    Nature. 1982 Jun 10;297(5866):479-83 PMID: 6283358
  32. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
    J Mol Appl Genet. 1982;1(4):327-41 PMID: 6286831
  33. A simple method for displaying the hydropathic character of a protein.
    J Mol Biol. 1982 May 5;157(1):105-32 PMID: 7108955
  34. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.
    J Virol. 1982 Jul;43(1):294-304 PMID: 6287003
  35. Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus.
    Science. 1982 Sep 3;217(4563):934-6 PMID: 6287572
  36. Mechanism of activation of a human oncogene.
    Nature. 1982 Nov 11;300(5888):143-9 PMID: 6290897
  37. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.
    Nature. 1982 Nov 11;300(5888):149-52 PMID: 7133135
  38. Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes.
    J Virol. 1982 Nov;44(2):509-19 PMID: 6292515
  39. Contributions of the depletions of guanine and adenine nucleotides to the toxicity of purine starvation in the mouse T lymphoma cell line.
    Cancer Res. 1983 Apr;43(4):1587-91 PMID: 6600962
  40. Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant.
    Nature. 1983 Apr 28;302(5911):842-4 PMID: 6843652
  41. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.
    Nature. 1983 Jun 30;303(5920):775-9 PMID: 6866079
  42. Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins.
    Cell. 1984 Mar;36(3):607-12 PMID: 6365329
  43. Homologies in the primary structure of GTP-binding proteins: the nucleotide-binding site of EF-Tu and p21.
    EMBO J. 1984 Feb;3(2):339-41 PMID: 6609071
  44. An altered DNA sequence encompassing the ras gene of Harvey murine sarcoma virus.
    Nucleic Acids Res. 1984 Jul 25;12(14):5583-8 PMID: 6087292
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1986-07-00
Pages
2646-54
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC367821
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]